SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ProMetic Life Sciences
An SI Board Since April 2016
Posts SubjectMarks Bans Symbol
250 11 0 PLI.TO
Emcee:  axial Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
150New findings from late-stage clinical trial evaluating IVIG in patients sufferinstocker22-11/23/2017
149PROMETIC REPORTS POSITIVE INTERIM CLINICAL DATA FROM ONGOING INTRAVENOUS IMMUaxial-11/22/2017
148'RDR:How is Ryplazim administered? Laurin: It is an infusion that initiallyaxial-11/17/2017
147CORPORATE PRESENTATION TO ACCOMPANY Q3/17 WEBCAST — prometic.com Jimaxial-11/15/2017
146TRANSCRIPT — PROMETIC WEBCAST Q3 2017 stockhouse.com Jimaxial-11/15/2017
145RBC report — Q3 2017 docdro.id [graphic] Jimaxial-11/15/2017
144PROMETIC REPORTS 2017 THIRD QUARTER HIGHLIGHTS AND FINANCIAL RESULTS US $80 milaxial111/13/2017
143Plasminogen Deficiency Awareness Week videos. youtube.com I hope that link wiCush111/10/2017
142PROMETIC TO REPORT ITS THIRD QUARTER 2017 FINANCIAL RESULTS AND TO HOLD CONFERENaxial-11/9/2017
141FINALLY! Cantor Fitzgerald weighs in. Prometic Life Sciences, Inc. (PLI.TO- C$1axial111/2/2017
140PROMETIC RECEIVES CLEARANCE FROM THE SWEDISH MEDICAL PRODUCTS AGENCY TO INITIATEaxial-11/1/2017
139[graphic] You be the judge ... in spite of now-assured financing until ~Q1 2019axial-10/30/2017
138PROMETIC RECEIVES CLEARANCE FROM THE SWEDISH MEDICAL PRODUCTS AGENCY TO INITIATaxial110/26/2017
137PROMETIC RECEIVES FAST TRACK DESIGNATION FOR PBI-4050 IN DEVELOPMENT FOR IDIOPATaxial110/25/2017
136PROMETIC ENTERS INTO BINDING LETTER OF INTENT TO SECURE USD $80 MILLION (CAD $axial-10/23/2017
135And another ... 'PROMETIC PRESENTS PBI-4050 AND PBI-4547 IN VIVO DATA AT Aaxial-10/21/2017
134Another brick in the wall — PROMETIC RECEIVES PRIORITY REVIEW STATUS FROM HEALaxial-10/19/2017
133Panmure Gordon — ProMetic Life Sciences 'Show me a drug developer that doesaxial-10/13/2017
132Prometic CEO Talks Plasminogen Deficiency ... 'RDR: What did the efficacy daxial-10/13/2017
131PROMETIC ANNOUNCES FDA ACCEPTANCE OF ITS BIOLOGICS LICENSE APPLICATION FOR PLASMaxial-10/13/2017
130The Wall of Worry ... 1 — RBC Update 2 — Canaccord Genuity Repaxial-9/26/2017
129Corporate Presentation September 2017 *** Note to readers *** — For newer reaaxial-9/25/2017
128PROMETIC RECEIVES FDA CLEARANCE OF ITS IND TO INITIATE PIVOTAL PBI-4050 PHASE 2axial-9/25/2017
127Update — Prometic pipeline September 2017 [graphic] Jimaxial-9/22/2017
126PROMETIC REPORTS POSITIVE CLINICAL DATA FROM ONGOING PBI-4050 STUDY IN ALSTRaxial19/19/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News